News Releases

09/26/19	Millendo Therapeutics to Present at Prader-Willi Syndrome Conferences
08/29/19	Millendo Therapeutics to Participate in September Investor Conferences
08/20/19	Millendo Therapeutics Appoints Tamara Joseph as General Counsel and Ryan Zeidan as Chief Development Officer
08/12/19	Millendo Therapeutics Reports Second Quarter 2019 Operating and Financial Results
08/01/19	Millendo Therapeutics to Participate in August Investor Conferences
06/18/19	Millendo Therapeutics Announces Departure of Chief Medical Officer
05/23/19	Millendo Therapeutics to Present at Jefferies 2019 Healthcare Conference
05/15/19	Millendo Therapeutics Reports First Quarter 2019 Operating and Financial Results
05/08/19	Millendo Therapeutics Announces 21st European Congress of Endocrinology 2019 Presentations on Livoletide for Prader-Willi Syndrome and Nevanimibe for Classic Congenital Adrenal Hyperplasia
05/02/19	Millendo Therapeutics to Participate in May Investor Conferences

News Releases

Shareholder Tools